In an age of increasingly individualized healthcare, Elizabeth Philp has become a significant figure of innovation, especially in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the vanguard of a movement to make bespoke medications more obtainable, challenging the traditional one-size-fits-all